• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology

    1/14/25 4:00:00 AM ET
    $PDD
    $WBX
    Business Services
    Consumer Discretionary
    Industrial Specialties
    Consumer Discretionary
    Get the next $PDD alert in real time by email
    • Bioptimus announces a $76M funding milestone, with the latest injection of $41M led by Cathay Innovation less than 12 months from its initial seed round
    • Since the successful release of the largest AI foundation model for pathology in July, the company has been continuing its groundbreaking work and is now poised to release a breakthrough new multi-scale, multi-modal foundation model for biology in 2025
    • The new model will allow the simulation of biology at unprecedented scale and dimension, creating biological innovation for medical, biotech, cosmetic industries, and beyond

    Bioptimus, the pioneering AI foundation model company, announced today that it has reached a significant funding milestone of $76 million. This total includes a $41 million cash injection, led by Cathay Innovation with participation from prominent investors, including Sofinnova Partners, Bpifrance through its Large Venture Fund, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf. The funding will accelerate Bioptimus's mission to build the world's first universal AI foundation model for biology, aimed at revolutionizing research and innovation across the medical, biotech, cosmetic industries, and beyond.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114054102/en/

    The company has been building momentum this year, assembling a world-class team, securing access to unique data sources, and successfully releasing its first model, H-Optimus-0, the world's largest foundation model for pathology. H-Optimus-0 has already outperformed all other pathology models in independent benchmarks, including assessments conducted by Harvard Medical School's HEST program1 and the University of Leeds.2 These studies highlighted the model's unparalleled ability to predict gene expression from morphology and to subtype ovarian cancer with exceptional accuracy.

    Breaking Down Silos in Biology

    Bioptimus is redefining how we approach biological research by addressing a longstanding issue: the siloed nature of biological understanding. Historically, research has focused on isolated biological components, such as DNA, proteins, cells or tissues. Even existing AI foundation models operate within these silos, limiting their potential impact. Bioptimus's revolutionary approach integrates data across multiple scales (molecules, cells, tissues, organisms) and modalities (imaging, genetics, etc), enabling a holistic view of biology as it exists in reality.

    Jean-Philippe Vert, co-founder and CEO of Bioptimus, stated: "What we are building is not just a technological breakthrough; it's a transformative tool for understanding biology in its full complexity. By learning how biology works directly from raw data across scales, from molecules to whole organisms, our model will empower researchers in the pharmaceutical industry to simulate complex biology, predict disease outcomes and response to treatment, and design therapies with unprecedented precision. Beyond pharmaceuticals, this model will unlock limitless possibilities across many other industries, driving biological discoveries in ways we are only beginning to imagine. Essentially, it's like the GPT of biology—but instead of generating text, we're simulating biology."

    The funding will enable Bioptimus to enhance its multi-modal AI platform, integrating even more diverse data sources and therapeutic areas, forge strategic partnerships with pharmaceutical and biotech companies and expand critical datasets to further refine and validate its models.

    Jacky Abitbol, Partner at Cathay Innovation, said: "Bioptimus is at the forefront of transforming biological research, leveraging cutting-edge AI to break down silos and unlock the full complexity of biology. By integrating data across multiple scales and modalities, Bioptimus is paving the way for groundbreaking innovations across industries, from pharmaceuticals to biotechnology and beyond. We are delighted to see that since our initial investment a year ago, Bioptimus has succeeded in structuring a world-class team, while achieving key milestones in its development, notably with the launch of its AI foundation model for pathology in July, the largest in the world."

    By combining the power of AI with a truly integrated view of biology, Bioptimus will empower researchers and multiple industries to solve some of the most complex challenges in medicine, biotechnology, and beyond.

    For more information, visit bioptimus.com.

    About Cathay Innovation

    Cathay Innovation is a multistage venture capital firm, affiliated to Cathay Capital, investing in founders building transformative businesses across Europe, North America, Asia, Latin America and Africa. Its platform connects founders with investors and its ecosystem of leading Fortune500 corporations to help startups scale and transform industries with consumer to enterprise and AI solutions in commerce, fintech, digital health and mobility / energy. Founded in Paris in 2015, Cathay Innovation now manages over €2.5B AUM with additional offices in Berlin, San Francisco, Shanghai and Singapore and has invested in over 100 startups including Chime, Pinduoduo (NASDAQ:PDD), Glovo, Wallbox (NYSE:WBX), Owkin, Getaround, Ledger, ZenBusiness, Alma, Descartes Underwriting and more.

    To learn more, visit us at www.cathayinnovation.com or follow us on LinkedIn or Twitter @cathayinnov.

    ____________________________________

    1 Mahmood Lab, 2024. HEST: Hierarchical Embedding of Spatial Transcriptomics. Available at: https://github.com/mahmoodlab/HEST

    2 Arxiv.org, 2024. A New Model for Data Processing in Neural Networks. Available at: https://arxiv.org/abs/2405.09990

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250114054102/en/

    Media Contact: [email protected]

    Get the next $PDD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PDD
    $WBX

    CompanyDatePrice TargetRatingAnalyst
    PDD Holdings Inc.
    $PDD
    3/21/2025$137.00 → $130.00Buy → Neutral
    Nomura
    PDD Holdings Inc.
    $PDD
    11/22/2024Overweight → Neutral
    Analyst
    Wallbox N.V.
    $WBX
    10/30/2024Buy → Hold
    Stifel
    PDD Holdings Inc.
    $PDD
    10/7/2024$126.00 → $224.00Neutral → Outperform
    Macquarie
    PDD Holdings Inc.
    $PDD
    8/27/2024$194.00 → $120.00Buy → Neutral
    Citigroup
    PDD Holdings Inc.
    $PDD
    8/26/2024Outperform → Neutral
    Macquarie
    PDD Holdings Inc.
    $PDD
    8/26/2024$193.00 → $151.00Buy
    Jefferies
    PDD Holdings Inc.
    $PDD
    5/24/2024$145.00 → $184.00Neutral → Buy
    Goldman
    More analyst ratings

    $PDD
    $WBX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Wallbox Announces First Quarter 2025 Financial Results

      Wallbox N.V. (NYSE:WBX), a leading provider of electric vehicle ("EV") charging and energy management solutions worldwide, today announced its financial results for the first quarter ended March 31, 2025 and provided a business update. First Quarter 2025 Highlights and Business Update: Generated revenue of €37.6 million in the quarter exceeding the guidance provided last quarter Improved Gross Margin by 634 basis points quarter over quarter, now landing at 38.1% for the first quarter of 2025, within our target range Adjusted EBITDA was €(7.8) million representing a 42% improvement quarter-over-quarter North American sales maintained strong momentum, growing by 142% compared to the

      5/7/25 6:50:00 AM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary
    • Wallbox Announces Filing of 2024 Annual Report on Form 20-F

      Wallbox (NYSE:WBX), a leading provider of electric vehicle (EV) charging and energy management solutions worldwide, today announced that its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, has been filed with the Securities and Exchange Commission (SEC). The Annual Report on Form 20-F can be accessed on the Investor Relations section of Wallbox's website at investors.wallbox.com and on the SEC's website at www.sec.gov. Wallbox's security holders may request free of charge a hard copy of Wallbox's complete audited financial statements by contacting [email protected]. About Wallbox Wallbox is a global technology company, dedicated to changing the way the world u

      5/6/25 4:30:00 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary
    • Wallbox and Nissan Canada Launch Nationwide Home EV Charging Partnership

      Wallbox (NYSE:WBX), a global leader in electric vehicle (EV) charging and energy management solutions, today announced a new partnership with Nissan Canada to launch a nationwide integrated home charging solution for Nissan electric vehicle owners. As part of this program, RocketEV, one of Canada's leading EV charger installers, will provide professional installation services, helping deliver a seamless, one-stop shop experience for both new and existing Nissan EV drivers. The program is designed to simplify the home charging journey and make it more accessible to a broader audience. Starting in May, Nissan EV owners across Canada will be able to purchase Wallbox's Pulsar Plus home charge

      5/1/25 8:00:00 AM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary

    $PDD
    $WBX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • PDD Holdings downgraded by Nomura with a new price target

      Nomura downgraded PDD Holdings from Buy to Neutral and set a new price target of $130.00 from $137.00 previously

      3/21/25 8:04:52 AM ET
      $PDD
      Business Services
      Consumer Discretionary
    • Pinduoduo downgraded by Analyst

      Analyst downgraded Pinduoduo from Overweight to Neutral

      11/22/24 9:29:05 AM ET
      $PDD
      Business Services
      Consumer Discretionary
    • Wallbox downgraded by Stifel

      Stifel downgraded Wallbox from Buy to Hold

      10/30/24 7:30:38 AM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary

    $PDD
    $WBX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Wallbox N.V.

      SC 13G/A - Wallbox N.V. (0001866501) (Subject)

      11/12/24 4:30:30 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary
    • SEC Form SC 13D filed by Wallbox N.V.

      SC 13D - Wallbox N.V. (0001866501) (Subject)

      8/7/24 6:25:02 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Wallbox N.V. (Amendment)

      SC 13G/A - Wallbox N.V. (0001866501) (Subject)

      2/13/24 2:18:54 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary

    $PDD
    $WBX
    Financials

    Live finance-specific insights

    See more
    • Wallbox Announces First Quarter 2025 Financial Results

      Wallbox N.V. (NYSE:WBX), a leading provider of electric vehicle ("EV") charging and energy management solutions worldwide, today announced its financial results for the first quarter ended March 31, 2025 and provided a business update. First Quarter 2025 Highlights and Business Update: Generated revenue of €37.6 million in the quarter exceeding the guidance provided last quarter Improved Gross Margin by 634 basis points quarter over quarter, now landing at 38.1% for the first quarter of 2025, within our target range Adjusted EBITDA was €(7.8) million representing a 42% improvement quarter-over-quarter North American sales maintained strong momentum, growing by 142% compared to the

      5/7/25 6:50:00 AM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary
    • PDD Holdings Announces Fourth Quarter 2024 and Fiscal Year 2024 Unaudited Financial Results

      DUBLIN and SHANGHAI, March 20, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the fourth quarter ended and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Total revenues in the quarter were RMB110,610.1 million (US$115,153.5 million), an increase of 24% from RMB88,881.0 million in the same quarter of 2023.Operating profit in the quarter was RMB25,592.2 million (US$3,506.1 million), an increase of 14% from RMB22,395.0 million in the same quarter of 2023. Non-GAAP2 operating profit in the quarter was RMB27,99

      3/20/25 6:30:31 AM ET
      $PDD
      Business Services
      Consumer Discretionary
    • PDD Holdings to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025

      DUBLIN and SHANGHAI, March 13, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD) today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, before U.S. markets open on Thursday, March 20, 2025. The Company's management will hold an earnings conference call at 7:30 AM ET on March 20, 2025 (11:30 AM GMT and 7:30 PM HKT on the same day). The conference call will be webcast live at https://investor.pddholdings.com/investor-events. The webcast will be available for replay at the same website following the conclusion of the call. About PDD Holdings: PDD Holdings is a multinational

      3/13/25 7:30:28 AM ET
      $PDD
      Business Services
      Consumer Discretionary

    $PDD
    $WBX
    SEC Filings

    See more
    • SEC Form 6-K filed by Wallbox N.V.

      6-K - Wallbox N.V. (0001866501) (Filer)

      5/7/25 4:06:57 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary
    • Amendment: SEC Form 6-K/A filed by Wallbox N.V.

      6-K/A - Wallbox N.V. (0001866501) (Filer)

      5/6/25 9:37:24 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary
    • SEC Form 20-F filed by Wallbox N.V.

      20-F - Wallbox N.V. (0001866501) (Filer)

      5/6/25 1:28:21 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary

    $PDD
    $WBX
    Leadership Updates

    Live Leadership Updates

    See more
    • Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

      The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Eme

      11/28/24 8:06:00 AM ET
      $BZ
      $HUYA
      $LI
      $PDD
      Computer Software: Programming Data Processing
      Technology
      Auto Manufacturing
      Consumer Discretionary
    • AI WealthTech company Range Raises $28 Million Series B Led by Cathay Innovation

      The new face of wealth management creates ai powered software to drive optimization; membership is increasing 20% MoM, Appoints Chris Davidson of House Call Pro as CTO MCLEAN, Va., Nov. 26, 2024 /PRNewswire/ -- Range, the all-in-one AI WealthTech platform, raised $28 million in Series B funding, led by Cathay Innovation and joined by Gradient Ventures and other investors. This round brings the company's total funding to $40 million. Traditional financial advisors have offered the same types of wealth management services to consumers for decades. Range is overhauling the sector

      11/26/24 8:00:00 AM ET
      $PDD
      $WBX
      Business Services
      Consumer Discretionary
      Industrial Specialties
    • Wallbox Announces Additions to Board of Directors at Annual General Meeting

      Wallbox (NYSE:WBX), a leading provider of electric vehicle (EV) charging solutions, today announced the addition of three new members to its Board of Directors at its 2024 Annual General Meeting of Shareholders. The three new Directors voted in by shareholders at this year's Annual General Meeting include Jordi Lainz, who previously served as Wallbox CFO for close to six years; Ferdinand Schlutius, Co-CEO of ABL, a pioneer in EV charging solutions in Germany which was acquired by Wallbox in 2023; and Paolo Campinoti, Executive Vice President with commercial responsibility over EMEA, APAC and LATAM for Generac, which is a minority investor in Wallbox. Full bios on the three new Directors f

      6/7/24 4:25:00 PM ET
      $WBX
      Industrial Specialties
      Consumer Discretionary